BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 10190564)

  • 1. Comparison of the DNA adducts formed by tamoxifen and 4-hydroxytamoxifen in vivo.
    Beland FA; McDaniel LP; Marques MM
    Carcinogenesis; 1999 Mar; 20(3):471-7. PubMed ID: 10190564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA adduct formation and mutant induction in Sprague-Dawley rats treated with tamoxifen and its derivatives.
    Gamboa da Costa G; McDaniel-Hamilton LP; Heflich RH; Marques MM; Beland FA
    Carcinogenesis; 2001 Aug; 22(8):1307-15. PubMed ID: 11470763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of 4-hydroxytamoxifen and the tamoxifen derivative metabolite E by uterine peroxidase to form DNA adducts: comparison with DNA adducts formed in the uterus of Sprague-Dawley rats treated with tamoxifen.
    Pathak DN; Pongracz K; Bodell WJ
    Carcinogenesis; 1996 Sep; 17(9):1785-90. PubMed ID: 8824496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of tamoxifen-DNA adducts formed by 4-hydroxytamoxifen quinone methide.
    Marques MM; Beland FA
    Carcinogenesis; 1997 Oct; 18(10):1949-54. PubMed ID: 9364005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Organ specificity of DNA adduct formation by tamoxifen and alpha-hydroxytamoxifen in the rat: implications for understanding the mechanism(s) of tamoxifen carcinogenicity and for human risk assessment.
    Phillips DH; Hewer A; Osborne MR; Cole KJ; Churchill C; Arlt VM
    Mutagenesis; 2005 Jul; 20(4):297-303. PubMed ID: 15928012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tamoxifen metabolic activation: comparison of DNA adducts formed by microsomal and chemical activation of tamoxifen and 4-hydroxytamoxifen with DNA adducts formed in vivo.
    Moorthy B; Sriram P; Pathak DN; Bodell WJ; Randerath K
    Cancer Res; 1996 Jan; 56(1):53-7. PubMed ID: 8548775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA adducts formed from 4-hydroxytamoxifen are more mutagenic than those formed by alpha-acetoxytamoxifen in a shuttle vector target gene replicated in human Ad293 cells.
    McLuckie KI; Routledge MN; Brown K; Gaskell M; Farmer PB; Roberts GC; Martin EA
    Biochemistry; 2002 Jul; 41(28):8899-906. PubMed ID: 12102632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of lacI mutations in Big Blue rats treated with tamoxifen and alpha-hydroxytamoxifen.
    Gamboa da Costa G; Manjanatha MG; Marques MM; Beland FA
    Cancer Lett; 2002 Feb; 176(1):37-45. PubMed ID: 11790452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of tamoxifen and alpha-hydroxytamoxifen 32P-post-labelled DNA adducts by the development of a novel automated on-line solid-phase extraction HPLC method.
    Martin EA; Heydon RT; Brown K; Brown JE; Lim CK; White IN; Smith LL
    Carcinogenesis; 1998 Jun; 19(6):1061-9. PubMed ID: 9667745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tamoxifen: evidence by 32P-postlabeling and use of metabolic inhibitors for two distinct pathways leading to mouse hepatic DNA adduct formation and identification of 4-hydroxytamoxifen as a proximate metabolite.
    Randerath K; Moorthy B; Mabon N; Sriram P
    Carcinogenesis; 1994 Oct; 15(10):2087-94. PubMed ID: 7955037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microsomal and peroxidase activation of 4-hydroxy-tamoxifen to form DNA adducts: comparison with DNA adducts formed in Sprague-Dawley rats treated with tamoxifen.
    Pathak DN; Pongracz K; Bodell WJ
    Carcinogenesis; 1995 Jan; 16(1):11-5. PubMed ID: 7834794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Major inter-species differences in the rates of O-sulphonation and O-glucuronylation of alpha-hydroxytamoxifen in vitro: a metabolic disparity protecting human liver from the formation of tamoxifen-DNA adducts.
    Boocock DJ; Maggs JL; Brown K; White IN; Park BK
    Carcinogenesis; 2000 Oct; 21(10):1851-8. PubMed ID: 11023543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 4-Hydroxylated metabolites of the antiestrogens tamoxifen and toremifene are metabolized to unusually stable quinone methides.
    Fan PW; Zhang F; Bolton JL
    Chem Res Toxicol; 2000 Jan; 13(1):45-52. PubMed ID: 10649966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of tamoxifen DNA adducts using on-line sample preparation and HPLC-electrospray ionization tandem mass spectrometry.
    Gamboa da Costa G; Marques MM; Beland FA; Freeman JP; Churchwell MI; Doerge DR
    Chem Res Toxicol; 2003 Mar; 16(3):357-66. PubMed ID: 12641436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the major DNA adduct formed by alpha-hydroxy-N-desmethyltamoxifen in vitro and in vivo.
    Gamboa da Costa G; Hamilton LP; Beland FA; Marques MM
    Chem Res Toxicol; 2000 Mar; 13(3):200-7. PubMed ID: 10725117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of N,N-didesmethyltamoxifen upon DNA adduct formation by tamoxifen and alpha-hydroxytamoxifen.
    Gamboa da Costa G; Marques MM; Fu X; Churchwell MI; Wang YP; Doerge DR; Beland FA
    Cancer Lett; 2007 Nov; 257(2):191-8. PubMed ID: 17765393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha-hydroxytamoxifen, a genotoxic metabolite of tamoxifen in the rat: identification and quantification in vivo and in vitro.
    Boocock DJ; Maggs JL; White IN; Park BK
    Carcinogenesis; 1999 Jan; 20(1):153-60. PubMed ID: 9934863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 4-Hydroxytamoxifen gives DNA adducts by chemical activation, but not in rat liver cells.
    Osborne MR; Davis W; Hewer AJ; Hardcastle IR; Phillips DH
    Chem Res Toxicol; 1999 Feb; 12(2):151-8. PubMed ID: 10027792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of tamoxifen-DNA adducts formed by alpha-sulfate tamoxifen and alpha-acetoxytamoxifen.
    Dasaradhi L; Shibutani S
    Chem Res Toxicol; 1997 Feb; 10(2):189-96. PubMed ID: 9049430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex differences in the activation of tamoxifen to DNA binding species in rat liver in vivo and in rat hepatocytes in vitro: role of sulfotransferase induction.
    Davis W; Hewer A; Rajkowski KM; Meinl W; Glatt H; Phillips DH
    Cancer Res; 2000 Jun; 60(11):2887-91. PubMed ID: 10850433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.